These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
131 related articles for article (PubMed ID: 9769121)
1. Morphogenetic concepts of normal and abnormal growth in the human prostate. Bonkhoff H; Remberger K Virchows Arch; 1998 Sep; 433(3):195-202. PubMed ID: 9769121 [TBL] [Abstract][Full Text] [Related]
2. [Morphogenesis of benign prostatic hyperplasia and prostatic carcinoma]. Bonkhoff H; Remberger K Pathologe; 1998 Jan; 19(1):12-20. PubMed ID: 9541938 [TBL] [Abstract][Full Text] [Related]
3. Differentiation pathways and histogenetic aspects of normal and abnormal prostatic growth: a stem cell model. Bonkhoff H; Remberger K Prostate; 1996 Feb; 28(2):98-106. PubMed ID: 8604398 [TBL] [Abstract][Full Text] [Related]
4. Morphogenetic aspects of normal and abnormal prostatic growth. Bonkhoff H; Remberger K Pathol Res Pract; 1995 Sep; 191(9):833-5. PubMed ID: 8606860 [TBL] [Abstract][Full Text] [Related]
5. Significance of abnormal diploid DNA histograms in localized prostate cancer and adjacent benign prostatic tissue. Deitch AD; Miller GJ; deVere White RW Cancer; 1993 Sep; 72(5):1692-700. PubMed ID: 7688657 [TBL] [Abstract][Full Text] [Related]
7. DNA methylation as a dynamic regulator of development and disease processes: spotlight on the prostate. Keil KP; Vezina CM Epigenomics; 2015; 7(3):413-25. PubMed ID: 26077429 [TBL] [Abstract][Full Text] [Related]
8. A system for studying epithelial-stromal interactions reveals distinct inductive abilities of stromal cells from benign prostatic hyperplasia and prostate cancer. Barclay WW; Woodruff RD; Hall MC; Cramer SD Endocrinology; 2005 Jan; 146(1):13-8. PubMed ID: 15471963 [TBL] [Abstract][Full Text] [Related]
10. FGF17 is an autocrine prostatic epithelial growth factor and is upregulated in benign prostatic hyperplasia. Polnaszek N; Kwabi-Addo B; Wang J; Ittmann M Prostate; 2004 Jun; 60(1):18-24. PubMed ID: 15129425 [TBL] [Abstract][Full Text] [Related]
11. Mesenchymal-epithelial interactions and transforming growth factor-beta 1 expression during normal and abnormal prostatic growth. Timme TL; Truong LD; Slawin KM; Kadmon D; Park SH; Thompson TC Microsc Res Tech; 1995 Mar; 30(4):333-41. PubMed ID: 7541677 [TBL] [Abstract][Full Text] [Related]
12. Polymorphisms of fibroblast growth factor receptor 4 have association with the development of prostate cancer and benign prostatic hyperplasia and the progression of prostate cancer in a Japanese population. Ma Z; Tsuchiya N; Yuasa T; Inoue T; Kumazawa T; Narita S; Horikawa Y; Tsuruta H; Obara T; Saito M; Satoh S; Ogawa O; Habuchi T Int J Cancer; 2008 Dec; 123(11):2574-9. PubMed ID: 18756523 [TBL] [Abstract][Full Text] [Related]
13. The expanding role of epigenetics in the development, diagnosis and treatment of prostate cancer and benign prostatic hyperplasia. Dobosy JR; Roberts JL; Fu VX; Jarrard DF J Urol; 2007 Mar; 177(3):822-31. PubMed ID: 17296351 [TBL] [Abstract][Full Text] [Related]
14. Prostate development and growth in benign prostatic hyperplasia. Timms BG; Hofkamp LE Differentiation; 2011; 82(4-5):173-83. PubMed ID: 21939815 [TBL] [Abstract][Full Text] [Related]
15. Role of canine basal cells in prostatic post natal development, induction of hyperplasia, sex hormone-stimulated growth; and the ductal origin of carcinoma. Leav I; Schelling KH; Adams JY; Merk FB; Alroy J Prostate; 2001 May; 47(3):149-63. PubMed ID: 11351344 [TBL] [Abstract][Full Text] [Related]
16. Diagnostic investigations of canine prostatitis incidence together with benign prostate hyperplasia, prostate malignancies, and biochemical recurrence in high-risk prostate cancer as a model for human study. Shafiee R; Shariat A; Khalili S; Malayeri HZ; Mokarizadeh A; Anissian A; Ahmadi MR; Hosseini E; Naderafif M; Mohsenzadeh S; Rasoulian MH; Rezapour R; Pourzaer M Tumour Biol; 2015 Apr; 36(4):2437-45. PubMed ID: 25420908 [TBL] [Abstract][Full Text] [Related]
17. A Review of Prostate Organogenesis and a Role for iPSC-Derived Prostate Organoids to Study Prostate Development and Disease. Buskin A; Singh P; Lorenz O; Robson C; Strand DW; Heer R Int J Mol Sci; 2021 Dec; 22(23):. PubMed ID: 34884905 [TBL] [Abstract][Full Text] [Related]
18. Associations between polymorphisms in the steroid 5-alpha reductase type II (SRD5A2) gene and benign prostatic hyperplasia and prostate cancer. Salam MT; Ursin G; Skinner EC; Dessissa T; Reichardt JK Urol Oncol; 2005; 23(4):246-53. PubMed ID: 16018939 [TBL] [Abstract][Full Text] [Related]
19. Role of canine basal cells in postnatal prostatic development, induction of hyperplasia, and sex hormone-stimulated growth; and the ductal origin of carcinoma. Leav I; Schelling KH; Adams JY; Merk FB; Alroy J Prostate; 2001 Aug; 48(3):210-24. PubMed ID: 11494337 [TBL] [Abstract][Full Text] [Related]
20. Hypermethylation of Cyclin D2 is associated with loss of mRNA expression and tumor development in prostate cancer. Henrique R; Costa VL; Cerveira N; Carvalho AL; Hoque MO; Ribeiro FR; Oliveira J; Teixeira MR; Sidransky D; Jerónimo C J Mol Med (Berl); 2006 Nov; 84(11):911-8. PubMed ID: 17016690 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]